Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency

Supporting evidence

• Evaluation report

• Committee papers (PDF 4.89 MB)

  Published:

  22 May 2025